Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Lorch JH"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sehgal K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Thyroid Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Pappa T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Thyroid Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Shin KY; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Schiantarelli J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Liu M; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Ricker C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Besson NR; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Jones SM; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Welsh EL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Barletta JA; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Doherty GM; Thyroid Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Alexander EK; Thyroid Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Rodig SJ; Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., O'Neill A; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Van Allen E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Thyroid Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Lorch JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Thyroid Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts.; Head and Neck/Thyroid Program, Robert H. Lurie Cancer Center of Northwestern University, Chicago, Illinois.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.
Autor:
Schiantarelli J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Pappa T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA.; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA., Conway J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA.; Department of Biomedical Informatics, Harvard Medical School, Boston, MA., Crowdis J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Dietlein F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Huang J; Yale School of Medicine, New Haven, CT., Stanizzi D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Carey E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Bosma-Moody A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Imamovic A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Han S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA.; Department of Biological and Biomedical Sciences, Harvard Medical School, Boston, MA., Camp S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Kofman E; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA., Shannon E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Barletta JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA.; Harvard Graduate Program in Biophysics, Boston, MA., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Lorch JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Aug; Vol. 6, pp. e2200183.
Autor:
Wan Z; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Zhong AX; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Zhang S; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Pavlou G; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Coughlin MF; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Shelton SE; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Nguyen HT; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Lorch JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Kamm RD; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Publikováno v:
Small methods [Small Methods] 2022 Jun; Vol. 6 (6), pp. e2200143. Date of Electronic Publication: 2022 Apr 03.
Autor:
Tyan K; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham & Women's Hospital, Boston, Massachusetts, USA., Bae JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Lorch JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Margalit DN; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham & Women's Hospital, Boston, Massachusetts, USA., Tishler RB; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham & Women's Hospital, Boston, Massachusetts, USA., Huynh MA; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham & Women's Hospital, Boston, Massachusetts, USA., Jo VY; Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts, USA., Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Chau NG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; BC Cancer, Vancouver Center, Vancouver, British Columbia, Canada., Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Schoenfeld JD; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham & Women's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Head & neck [Head Neck] 2022 Mar; Vol. 44 (3), pp. 722-734. Date of Electronic Publication: 2021 Dec 19.
Autor:
Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. glenn_hanna@dfci.harvard.edu., O'Neill A; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Shin KY; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Wong K; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Jo VY; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Quinn CT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cutler JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Flynn M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lizotte PH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Annino DJ Jr; Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital and Head and Neck Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Goguen LA; Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital and Head and Neck Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kass JI; Reliant Medical Group, Worcester, Massachusetts., Rettig EM; Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital and Head and Neck Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Sethi RKV; Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital and Head and Neck Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lorch JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schoenfeld JD; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Margalit DN; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Tishler RB; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Everett PC; Department of Medical Oncology, Boston Medical Center, Boston, Massachusetts., Desai AM; Department of Hematology/Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Cavanaugh ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Egloff AM; Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital and Head and Neck Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Uppaluri R; Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital and Head and Neck Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Feb 01; Vol. 28 (3), pp. 468-478. Date of Electronic Publication: 2021 Oct 19.
Autor:
Zhao B; Department of Surgery, Brigham and Women's Hospital, Boston MA. Electronic address: https://twitter.com/@BixiaoZhao., Aggarwal A; Department of Surgery, Brigham and Women's Hospital, Boston MA., Marshall JA; Department of Surgery, Brigham and Women's Hospital, Boston MA., Barletta JA; Department of Pathology, Brigham and Women's Hospital, Boston MA., Kijewski MF; Department of Radiology, Brigham and Women's Hospital, Boston MA., Lorch JH; Head and Neck Center, Dana Farber Cancer Institute, Boston, MA. Electronic address: https://twitter.com/@DrLorch., Nehs MA; Department of Surgery, Brigham and Women's Hospital, Boston MA. Electronic address: mnehs@bwh.harvard.edu.
Publikováno v:
Surgery [Surgery] 2022 Jan; Vol. 171 (1), pp. 227-234. Date of Electronic Publication: 2021 Jul 29.
Autor:
Hanna GJ; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA. Electronic address: glenn_hanna@dfci.harvard.edu., ONeill A; Department of Data Science, Dana-Farber Cancer Institute, Boston, USA., Cutler JM; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA., Flynn M; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA., Vijaykumar T; Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, USA., Clark JR; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, USA., Wirth LJ; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, USA., Lorch JH; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA., Park JC; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, USA., Mito JK; Department of Pathology, Brigham & Women's Hospital, Boston, USA., Lohr JG; Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, USA., Kaufman J; Adenoid Cystic Carcinoma Research Foundation, USA., Burr NS; Adenoid Cystic Carcinoma Research Foundation, USA., Zon LI; Department of Stem Cell and Regenerative Biology, Boston Children's Hospital and Harvard Medical School, Boston, USA., Haddad RI; Department of Medical Oncology, Center for Head & Neck Oncology, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute, Boston, USA.
Publikováno v:
Oral oncology [Oral Oncol] 2021 Aug; Vol. 119, pp. 105366. Date of Electronic Publication: 2021 Jun 03.